U.S. Communications Stock News

TJX Companies (NYSE:TJX) reported strong quarterly and full year results, highlighting solid underlying business performance. The company approved a new $3b share repurchase authorization, signaling a continued focus on returning capital to shareholders. TJX also announced a 13% dividend increase, alongside more cautious sales and earnings guidance for the coming year. At a share price of $158.69, TJX Companies comes into this update after a 30.1% return over the past year and a 173.0%...

Earlier in February 2026, Cadence Design Systems reported fourth-quarter 2025 revenue of US$1,440.11 million and net income of US$388.14 million, alongside full-year 2025 revenue of US$5.30 billion and net income of US$1.11 billion, and issued 2026 guidance calling for up to US$6.00 billion in revenue and up to US$1.38 billion in GAAP net income. At the same time, Cadence launched its ChipStack AI Super Agent, a virtual AI assistant for chip designers that underscores how AI features are...

Uranium Energy, ticker NYSEAM:UEC, is seeking shareholder approval to gain control of Anfield Energy's Utah uranium mill. The proposed deal would give Uranium Energy access to a key U.S. processing facility and could reshape its uranium supply chain. Investors are watching the shareholder vote as a potential turning point for Uranium Energy's role in the domestic uranium sector. Uranium Energy is coming into this news with a share price of $15.38 and 5 year returns of about 7x, along with a...

Wondering if CACI International at around US$597 per share still offers value, or if most of the opportunity has already been reflected in the price? The stock has had a mixed recent run, with a 1% gain over the last 7 days, a 7.2% decline over 30 days, an 11.1% return year to date, and a 77.9% return over the past year, following a 102.4% return over 3 years and 175.8% over 5 years. These moves have kept CACI on many investors' watchlists, as they reassess what is already priced in and what...

Innoviva (INVA) has wrapped up FY 2025 with Q4 revenue of US$114.6 million and basic EPS of US$2.19, capping a trailing 12 month period where revenue was US$411.3 million and basic EPS reached US$4.02 alongside a reported net profit margin of 65.9% that was lifted by a US$161.6 million one off gain. Over the past few quarters, the company has seen revenue move from US$88.6 million in Q1 2025 to US$114.6 million in Q4 2025, while basic EPS shifted from a loss of US$0.74 in Q1 2025 to US$2.19...

Nomad Foods (NYSE:NOMD) closed FY 2025 with fourth quarter revenue of €773.1 million and a basic EPS loss of €0.07, capping a trailing twelve month revenue line of about €3.0 billion and EPS of €0.91 as margins compressed from a 7.3% net profit margin to 4.5% over the year. Over recent quarters, the company has seen quarterly revenue move from €793.4 million in Q4 2024 to €760.1 million in Q1 2025, €746.9 million in Q2 2025, €752.4 million in Q3 2025 and €773.1 million in Q4 2025. Basic EPS...

EMCOR Group (EME) closed out FY 2025 with fourth quarter revenue of US$4.5b and basic EPS of US$9.72, alongside net income excluding extra items of US$434.6m, setting a clear marker for its latest reporting season. The company reported quarterly revenue of US$3.8b and EPS of US$6.35 in Q4 2024, rising to US$4.5b and EPS of US$9.72 in Q4 2025. Trailing twelve month EPS was US$28.30 on revenue of US$17.0b, giving investors a results set that combines higher earnings, a 7.5% net margin and prior...

Intro TG Therapeutics (TGTX) just closed out FY 2025 with Q4 revenue of US$192.6 million and basic EPS of US$0.16, alongside trailing twelve month revenue of US$616.3 million and EPS of US$3.10. Over the past couple of years, the company has reported revenue increasing from US$83.9 million in Q3 2024 to US$192.6 million in Q4 2025. Quarterly basic EPS has ranged from US$0.03 in Q1 2025 to US$2.69 in Q3 2025 and US$0.16 in the latest quarter, framing this release as a check-in on how durable...

PROG Holdings (NYSE:PRG) announced a 7.7% increase in its quarterly dividend, signaling confidence in returning cash to shareholders. The company is managing revenue pressure tied to a weaker retail backdrop and the bankruptcy of a major partner. Management has tightened Progressive Leasing criteria and is leaning more on its buy now, pay later platform and recent acquisitions. PROG Holdings enters this phase of corporate change with its shares at $36.83 and a mixed return profile. The...

If you are wondering whether Cardinal Infrastructure Group is priced attractively today, you are not alone. The stock has been on many investors' watchlists as questions around its fair value grow louder. The share price sits at US$33.05, with returns of 2.5% over the last 7 days, 19.2% over the past 30 days, and 46.1% year to date. This has sharpened interest in what is actually built into the current valuation. Recent coverage has focused on Cardinal Infrastructure Group's role in the...

If you are wondering whether Crocs at around US$92.70 is a bargain or a trap, you are not alone. The stock has attracted a lot of attention from investors trying to work out what a fair price looks like. Recently, Crocs has had mixed share price returns, with a 3.9% decline over the last 7 days, a 10.2% gain over the last 30 days, a 6.6% gain year to date, an 8.1% decline over 1 year, a 26.0% decline over 3 years, and a 23.3% gain over 5 years. These moves have played out alongside ongoing...

Warner Bros. Discovery overview and recent stock context Warner Bros. Discovery (WBD) continues to attract investor attention as its share price sits at $28.80, with recent returns of 0.2% over the past 3 months and 1.51x over the past year. See our latest analysis for Warner Bros. Discovery. With the share price at $28.80, Warner Bros. Discovery has logged a 20% 90 day share price return and a very large 1 year total shareholder return, which suggests momentum has been building as investors...

Healthpeak Properties has advanced its plan to spin out its senior housing portfolio via the Janus Living IPO, filing a preliminary prospectus for class A-1 shares that are expected to list on the NYSE under the ticker JAN. The move, alongside CEO Scott Brinker's recent presentation at the Citi 2026 Global Property CEO Conference, highlights how Healthpeak is reshaping its portfolio focus and communicating its long-term vision to investors. Next, we'll examine how the planned Janus Living...

In February 2026, Baker Hughes announced it would supply 25 BRUSH Power Generation electric generators, Automatic Voltage Regulators and cubicles to Boom Supersonic, expanding a prior 2025 agreement to support 1.3 GW of onsite power capacity for AI-focused data centers through deliveries scheduled from mid-2026 to 2028. This contract underscores Baker Hughes’ push into higher-value Industrial & Energy Technology solutions, tying its generator portfolio directly to the fast-growing AI data...

Array Technologies (ARRY) has just wrapped up FY 2025 with Q4 revenue of US$226.0 million and a basic EPS loss of US$1.06, alongside trailing twelve month revenue of about US$1.3 billion and a TTM basic EPS loss of US$0.73. The company has seen quarterly revenue range from US$231.4 million in Q3 2024 to US$393.5 million in Q3 2025, while basic EPS has swung between a loss of US$1.02 in Q3 2024 and a profit of US$0.19 in Q2 2025. This sets up a story where investors are watching how...

Fastenal (NasdaqGS:FAST) reported a 59% year over year increase in CEO Daniel L. Florness's compensation in a new SEC filing. Multiple insiders have purchased Fastenal stock over the past six months. The company has been awarded nearly $8 million in government contracts over the last year. Fastenal, trading at around $45.68 per share, has seen its stock return 13.0% year to date and 25.9% over the past year, with longer term gains of 85.9% over three years and 133.3% over five years. In...

Intellia Therapeutics (NTLA) closed FY 2025 with Q4 revenue of US$23.0 million and a basic EPS loss of US$0.83, as the company continued to invest heavily in its gene editing pipeline. Over the last six quarters, revenue has moved from US$9.1 million in Q3 2024 to US$23.0 million in Q4 2025, while quarterly basic EPS losses have ranged between US$0.83 and US$1.34. This has left margins firmly in loss-making territory even as the top line scaled up. See our full analysis for Intellia...

Hinge Health (NYSE:HNGE) President James Pursley recently sold company shares, extending a pattern of insider transactions over the past year. The latest sale adds to ongoing insider activity that investors may track alongside the company’s trading performance and business developments. Hinge Health, trading at $43.67 at the last close, has seen its share price move 4.2% over the past week and 8.1% over the past month. Year to date, the stock shows a 4.1% decline, which gives investors some...

Ingredion (INGR) is back on investors’ radar after appointing Univar Solutions as the exclusive distributor for its pharmaceutical starches in the United States and Canada, expanding access to its excipient portfolio across pharmaceutical and nutraceutical customers. See our latest analysis for Ingredion. The Univar agreement arrives after a steady build in recent momentum, with Ingredion’s 90 day share price return of 8.93% and year to date share price return of 6.69%, even as the 1 year...

In February 2026, Visteon Corporation reported fourth-quarter and full-year 2025 results showing softer net income and earnings per share alongside slightly lower annual sales of US$3.77 billion, while its Board raised the quarterly dividend to US$0.375 per share payable on March 16, 2026, and confirmed 2026 sales guidance of US$3.63 billion to US$3.83 billion. At the same time, Visteon completed a US$225.93 million share repurchase program that retired about 7.17% of its shares, signaling a...

If you are wondering whether W. R. Berkley at around US$71.58 is giving you a fair deal or asking too much, the next sections will walk through what the current price really implies. The stock has delivered returns of 1.8% over the last 7 days, 6.5% over 30 days, 3.2% year to date and 18.5% over 1 year, with longer term figures of 71.6% over 3 years and 157.1% over 5 years that may influence how investors think about upside and risk today. Recent coverage of W. R. Berkley has focused on its...

If you are wondering whether Farmers & Merchants Bank of Long Beach is priced attractively at around US$8,435 per share, you are not alone. This article is built to help you frame that question clearly. The stock has been relatively steady in the short term, with a 0.2% 7 day decline and returns of 1.0% over 30 days, 1.9% year to date and 50.9% over the last year, plus 29.0% over 3 years and 24.3% over 5 years. Recent coverage of Farmers & Merchants Bank of Long Beach has focused on its...

Remitly Global has reported past fourth-quarter 2025 revenue of US$442.18 million and full-year revenue of US$1.64 billion, swung to profitability, issued positive 2026 guidance, and announced Sebastian J. Gunningham as its new CEO while co-founder Matt Oppenheimer remains Chairman. The combination of a return to net income, guidance for continued revenue growth, and leadership bringing deep payments and AI experience is reshaping how investors assess Remitly’s long-term role in digital...

If you are wondering whether Stryker's share price around US$386 still offers value, you are not alone; many investors are trying to work out what a fair price looks like today. Over shorter periods, the stock has seen returns of 3.6% over the last 7 days, 8.9% over the last 30 days and 10.9% year to date, while the 1 year return sits at 0.2% and the 3 and 5 year returns are 51.6% and 72.4% respectively. Recent news coverage around Stryker has mainly centered on its position as a large...